PepGen Inc./$PEPG
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
Ticker
$PEPG
Sector
Primary listing
Employees
57
Headquarters
Website
PepGen Inc. Metrics
BasicAdvanced
$395M
-
-$2.83
1.91
-
Price and volume
Market cap
$395M
Beta
1.91
52-week high
$6.72
52-week low
$0.88
Average daily volume
749K
Financial strength
Current ratio
13.147
Quick ratio
12.946
Long term debt to equity
8.75
Total debt to equity
10.689
Profitability
EBITDA (TTM)
-96.811
Effective tax rate (TTM)
0.66%
Management effectiveness
Return on assets (TTM)
-34.09%
Return on equity (TTM)
-62.25%
Valuation
Price to book
2.42
Price to tangible book (TTM)
2.42
Price to free cash flow (TTM)
-2.216
Free cash flow yield (TTM)
-45.13%
Free cash flow per share (TTM)
-2.591
Growth
Earnings per share change (TTM)
-4.80%
3-year earnings per share growth (CAGR)
-22.89%
PepGen Inc. News
AllArticlesVideos
PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer
Business Wire·3 days ago
PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer
Business Wire·4 days ago
PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for PepGen Inc. stock?
PepGen Inc. (PEPG) has a market cap of $395M as of December 12, 2025.
What is the P/E ratio for PepGen Inc. stock?
The price to earnings (P/E) ratio for PepGen Inc. (PEPG) stock is 0 as of December 12, 2025.
Does PepGen Inc. stock pay dividends?
No, PepGen Inc. (PEPG) stock does not pay dividends to its shareholders as of December 12, 2025.
When is the next PepGen Inc. dividend payment date?
PepGen Inc. (PEPG) stock does not pay dividends to its shareholders.
What is the beta indicator for PepGen Inc.?
PepGen Inc. (PEPG) has a beta rating of 1.91. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.